SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-023341
Filing Date
2022-06-15
Accepted
2022-06-15 17:16:46
Documents
12
Period of Report
2022-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K mnov-8k_20220614.htm   iXBRL 8-K 64170
  Complete submission text file 0001564590-22-023341.txt   193515

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnov-20220614.xsd EX-101.SCH 5597
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20220614_lab.xml EX-101.LAB 19321
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20220614_pre.xml EX-101.PRE 11492
6 EXTRACTED XBRL INSTANCE DOCUMENT mnov-8k_20220614_htm.xml XML 3555
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33185 | Film No.: 221018557
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences